Reference
Rauma I, et al. Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients. Journal of Neurology 269 : 824-835, No. 2, Feb 2022. Available from: URL: https://link.springer.com/article/10.1007/s00415-021-10664-w#availability-of-data-and-material
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1963, 27 (2023). https://doi.org/10.1007/s40278-023-42083-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-42083-8